All participants (n = 1193) | | |
Positive test results for Mycoplasma genitalium | 50 | 4.2 (3.2 to 5.5) |
Positive test results for Chlamydia trachomatis | 62 | 5.2 (4.0 to 6.6) |
Positive test results for Neisseria gonorrhoeae | 52 | 4.4 (3.3 to 5.7) |
Men/Trans clinic (n = 884) | | |
Indeterminate | 2 | 0.2 (0.0 to 0.8) |
Positive test results for M genitalium | 40 | 4.5 (3.3 to 6.1) |
• Symptomatic | 20 | 50.0 (33.8 to 66.2) |
• Macrolide resistance | 25 | 62.4 (45.8 to 77.3) |
Co-infections | | |
• M genitalium, C trachomatis, and N gonorrhoeae | 1 | 0.1 (0.0 to 0.6) |
• M genitalium and N gonorrhoeae | 4 | 0.5 (0.1 to 1.2) |
• C trachomatis and N gonorrhoeae | 11 | 1.2 (0.6 to 2.2) |
Women/Trans clinic (n = 309) | | |
Indeterminate | 3 | 1.0 (0.2 to 2.8) |
Positive test results for M genitalium | 10 | 3.2 (1.6 to 5.9) |
• Symptomatic | 4 | 40.0 (12.2 to 73.8) |
• Macrolide resistance | 4 | 40.0 (12.2 to 73.8) |
Co-infections | | |
• M genitalium and C trachomatis | 1 | 0.3 (0.0 to 1.8) |